Literature DB >> 20532025

An atomoxetine tutorial.

David Feifel1.   

Abstract

Entities:  

Year:  2007        PMID： 20532025      PMCID： PMC2880947     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


× No keyword cloud information.
  9 in total

1.  A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.

Authors:  Sharon B Wigal; James J McGough; James T McCracken; Joseph Biederman; Thomas J Spencer; Kelly L Posner; Tim L Wigal; Scott H Kollins; Tanya M Clark; David A Mays; Yuxin Zhang; Simon J Tulloch
Journal:  J Atten Disord       Date:  2005-08       Impact factor: 3.256

2.  Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study.

Authors:  Jason E Kemner; H Lynn Starr; Patrick E Ciccone; Christa G Hooper-Wood; R Steve Crockett
Journal:  Adv Ther       Date:  2005 Sep-Oct       Impact factor: 3.845

3.  Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.

Authors:  T Spencer; J Biederman; T Wilens; J Prince; M Hatch; J Jones; M Harding; S V Faraone; L Seidman
Journal:  Am J Psychiatry       Date:  1998-05       Impact factor: 18.112

4.  Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

Authors:  David Michelson; Albert J Allen; Joan Busner; Charles Casat; David Dunn; Christopher Kratochvil; Jeffrey Newcorn; F Randy Sallee; R Bart Sangal; Keith Saylor; Scott West; Douglas Kelsey; Joachim Wernicke; Nancy J Trapp; Donald Harder
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

5.  Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

Authors:  D Michelson; D Faries; J Wernicke; D Kelsey; K Kendrick; F R Sallee; T Spencer
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

6.  Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Authors:  Douglas K Kelsey; Calvin R Sumner; Charles D Casat; Daniel L Coury; Humberto Quintana; Keith E Saylor; Virginia K Sutton; Jill Gonzales; Sandra K Malcolm; Kory J Schuh; Albert J Allen
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

7.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Authors:  David Michelson; Lenard Adler; Thomas Spencer; Frederick W Reimherr; Scott A West; Albert J Allen; Douglas Kelsey; Joachim Wernicke; Anthony Dietrich; Denái Milton
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

8.  Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

Authors:  Thomas Spencer; John H Heiligenstein; Joseph Biederman; Douglas E Faries; Christopher J Kratochvil; C Keith Conners; William Z Potter
Journal:  J Clin Psychiatry       Date:  2002-12       Impact factor: 4.384

9.  Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.

Authors:  David Michelson; Jan K Buitelaar; Marina Danckaerts; Christopher Gillberg; Thomas J Spencer; Alessandro Zuddas; Douglas E Faries; Shuyu Zhang; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-07       Impact factor: 8.829
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.